Antisense and RNAi Therapeutics Market Size, Top Share

Research Methodology – Antisense and RNAi Therapeutics Market

At Straits Research, we adopt a rigorous 360° research approach that integrates both primary and secondary research methodologies. This ensures accuracy, reliability, and actionable insights for stakeholders. Our methodology for the Antisense and RNAi Therapeutics Market comprises the following key stages:

Market Indicator & Macro-Factor Analysis

Our baseline thesis for the Antisense and RNAi Therapeutics Market is developed by integrating key market indicators and macroeconomic variables. These include:

Factors considered while calculating market size and share:

The number of existing players in the antisense and RNAi therapeutics market.
The volume of products services sold or the number of users/clients.
The current and planned R&D expenditure on antisense and RNAi therapeutics.
The global and regional prevalence of diseases that can be treated using antisense and RNAi therapeutics.
The number and nature of patents held in the antisense and RNAi therapeutics sector.
The price structure of antisense and RNAi therapeutic treatments in different regions.
The regulatory landscape and the level of government funding or subsidies for antisense and RNAi therapies.

Key Market Indicators:

The global and regional estimates and projections for the antisense and RNAi therapeutics market size.
Company market shares and financial performance indicators of key players in the market.
Government spending on healthcare and specifically on RNAi and antisense therapies.
New product launches or approvals in the antisense and RNAi therapeutics market.
The number of ongoing clinical trials studying antisense and RNAi therapies and their results.

Growth Trends:

The rate of increase in R&D investment on antisense and RNAi therapeutics.
The growth rate in the prevalence of diseases that are being targeted by antisense and RNAi therapeutics.
Trends in technological advancements in antisense and RNAi therapies.
The growing acceptance and prescription of antisense and RNAi therapeutics by healthcare providers.
Trends in partnerships, collaborations, mergers, and acquisitions among the industry players.

Secondary Research

Our secondary research forms the foundation of market understanding and scope definition. We collect and analyze information from multiple reliable sources to map the overall ecosystem of the Antisense and RNAi Therapeutics Market. Key inputs include:

Company-Level Information

Annual reports, investor presentations, SEC filings
Company press releases and product launch announcements
Public executive interviews and earnings calls
Strategy briefings and M&A updates

Industry and Government Sources

Country-level industry associations and trade bodies
Government dossiers, policy frameworks, and official releases
Whitepapers, working papers, and public R&D initiatives
Relevant Associations for the Antisense and RNAi Therapeutics Market

Market Intelligence Sources

Broker reports and financial analyst coverage
Paid databases (Hoovers, Factiva, Refinitiv, Reuters, Statista, etc.)
Import/export trade data and tariff databases
Sector-specific journals, magazines, and news portals

Macro & Consumer Insights

Global macroeconomic indicators and their cascading effect on the industry
Demand–supply outlook and value chain analysis
Consumer behaviour, adoption rates, and commercialization trends

Primary Research

To validate and enrich our secondary findings, we conduct extensive primary research with industry stakeholders across the value chain. This ensures we capture both qualitative insights and quantitative validation. Our primary research includes:

Expert Insights & KOL Engagements

Key Opinion Leader (KOL) Engagements
Structured interviews with executives, product managers, and domain experts
Paid and barter-based interviews across manufacturers, distributors, and end-users

Focused Discussions & Panels

Discussions with stakeholders to validate demand-supply gaps
Group discussions on emerging technologies, regulatory shifts, and adoption barriers

Data Validation & Business POV

Cross-verification of market sizing and forecasts with industry insiders
Capturing business perspectives on growth opportunities and restraints

Data Triangulation & Forecasting

The final step of our research involves data triangulation ensuring accuracy through cross-verification of:

Demand-side analysis (consumption patterns, adoption trends, customer spending)
Supply-side analysis (production, capacity, distribution, and market availability)
Macroeconomic & microeconomic impact factors

Forecasting is carried out using proprietary models that combine: